Publicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (10)

2024

  1. Diadenosine pentaphosphate regulates dendrite growth and number in cultured hippocampal neurons

    Purinergic Signalling, Vol. 20, Núm. 2, pp. 115-125

2023

  1. P2X7 receptor inhibition ameliorates ubiquitin–proteasome system dysfunction associated with Alzheimer’s disease

    Alzheimer's Research and Therapy, Vol. 15, Núm. 1

  2. TNAP and P2X7R: New Plasma Biomarkers for Alzheimer’s Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 13

2022

  1. P2X7 receptor blockade reduces tau induced toxicity, therapeutic implications in tauopathies

    Progress in Neurobiology, Vol. 208

  2. Purinergic Signalling and Inflammation-Related Diseases

    Cells

  3. Studying the Role of P2X7 Receptor in Axonal Growth Using In Utero Electroporation Technique

    Methods in Molecular Biology (Humana Press Inc.), pp. 355-366

  4. TNAP upregulation is a critical factor in Tauopathies and its blockade ameliorates neurotoxicity and increases life-expectancy

    Neurobiology of Disease, Vol. 165

2015

  1. Age-related nuclear translocation of P2X6 subunit modifies splicing activity interacting with splicing factor 3A1

    PLoS ONE, Vol. 10, Núm. 4

  2. Tissue-nonspecific Alkaline Phosphatase Regulates Purinergic Transmission in the Central Nervous System during Development and Disease

    Computational and Structural Biotechnology Journal, Vol. 13, pp. 95-100

2013

  1. P2X receptors as targets for the treatment of status epilepticus

    Frontiers in Cellular Neuroscience, Vol. 7, Núm. NOV